Best Practices for Type 2 Diabetes Management: Update on Guidelines and New Treatment Advances

In this interactive presentation, Vivian A. Fonseca, MD, FRCP, provides an overview of best practices for the management of type 2 diabetes with the latest guidelines and emerging treatment approaches.
Vivian A. Fonseca, MD, FRCP

ClinicalThought

Join Vivian A. Fonesca, MD, FRCP, as he shares his thoughts on the results of the phase III LEADER trial, which demonstrated a cardiovascular benefit for liraglutide in patients with type 2 diabetes who have cardiovascular disease.

Vivian A. Fonseca, MD, FRCP Released: August 15, 2016
Jointly provided by Endocrine Society and Clinical Care Options, LLC.

For questions about content or obtaining CME credit, please contact the Endocrine Society at www.education.endocrine.org/contact.

Supported by educational grants from
Merck & Co., Inc.
Novo Nordisk

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue